ENTITY

Windtree Therapeutics (WINT US)

Analysis

Health Care • United States

Windtree Therapeutics, Inc. operates as a clinical-stage biopharmaceutical and medical device company. The Company focuses on developing novel therapeutics for the treatment of patients with acute cardiovascular and pulmonary diseases. Windtree Therapeutics serves customers in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00